accomplished the concurrent inhibition of IDO-1 in both tumors and tumor-draining lymph nodes (TDLNs) by siRNA-loaded cationic lipid-assisted nanoparticles (CLANsiIDO1) (118). The gene discussed is IDO1; the disease is neoplasm.